As of November 6, 2026, 4 holders' latest Schedule 13D or 13G filings report owning 5% or more of Teva Pharmaceutical Industries Ltd. The largest reported stake is Harel Insurance Investments & Financial Services Ltd.'s, at 6%. 8 filings are on record since July 17, 2025 (Schedule 13G/A, November 2, 2026).
Sell to companies like Teva Pharmaceutical Industries Ltd? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Harel Insurance Investments & Financial Services Ltd. · Sole voting: 0 · Shared voting: 69,390,266 · Sole dispositive: 0 · Shared dispositive: 70,418,201 · SCHEDULE 13G/A, 2026-11-02
- · Reporting person: Migdal Insurance & Financial Holdings Ltd · Sole voting: 0 · Shared voting: 61,689,363 · Sole dispositive: 0 · Shared dispositive: 61,689,363 · SCHEDULE 13G, 2026-02-17
- · Holder: Harel Insurance Investments & Financial Services Ltd · Percent: 6.3% · SCHEDULE 13G/A
- · Reporting person: Fmr LLC · Sole voting: 21,233,241 · Shared voting: 0 · Sole dispositive: 24,641,361 · Shared dispositive: 0 · SCHEDULE 13G/A, 2025-11-05
- · Holder: Harel Insurance Investments & Financial Services Ltd · Percent: 5.1% · SCHEDULE 13G
Teva Pharmaceutical Industries Ltd. has 8 Schedule 13D or 13G filings on record since 2025-07-17. 4 holders' latest filing reports 5% or more of ordinary shares, par value nis 0.10 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Harel Insurance Investments & Financial Services Ltd. | 6% | 70,418,201 | SCHEDULE 13G/A, 2026-11-02 | 2026-09-30 |
| Migdal Insurance & Financial Holdings Ltd | 5.37% | 61,689,363 | SCHEDULE 13G, 2026-02-17 | 2025-12-31 |
| Menora Mivtachim Holdings Ltd | 5% | 57,395,173 | SCHEDULE 13G, 2025-07-17 | 2025-07-16 |
| Phoenix Financial Ltd. | 5% | 57,383,158 | SCHEDULE 13G, 2025-07-22 | 2025-07-14 |
| Fmr LLC | 2.1% | 24,641,361 | SCHEDULE 13G/A, 2025-11-05 | 2025-09-30 |
Holding shares or following this stake? See who's behind Teva Pharmaceutical Industries Ltd. and the warning signs.
Free to see. No signup.
Keep reading
More on Teva Pharmaceutical Industries Ltd. and the records around it.
Teva Pharmaceutical Industries Ltd. elsewhere on the record
- Leadership changes Oct 2026
- Who owns it
Companies that share a holder
- Menora Mivtachim Holdings Ltd also filed stake reports on 7 other companies: CAMTEK LTD (Oct 2026), Ellomay Capital Ltd (Aug 2026), FORMULA SYSTEMS (1985) LTD (Aug 2026)
- Migdal Insurance & Financial Holdings Ltd also filed stake reports on 10 other companies: Camtek Ltd (Oct 2026), Enlight Renewable Energy Ltd (Jul 2026), Ormat Technologies, Inc. (Jul 2026)
- Harel Insurance Investments & Financial Services Ltd also filed stake reports on 16 other companies: Perion Network Ltd (Nov 2026), Tower Semiconductor Ltd (Nov 2026), ELBIT SYSTEMS LTD (Oct 2026)
Watch Teva Pharmaceutical Industries Ltd.
Get an email when Teva Pharmaceutical Industries Ltd. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Teva Pharmaceutical Industries Ltd.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Teva Pharmaceutical Industries Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Teva Pharmaceutical Industries Ltd. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
9 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Harel Insurance Investments & Financial Services Ltd. | 0 | 69,390,266 | 0 | 70,418,201 | SCHEDULE 13G/A, 2026-11-02 |
| Migdal Insurance & Financial Holdings Ltd | 0 | 61,689,363 | 0 | 61,689,363 | SCHEDULE 13G, 2026-02-17 |
| Fmr LLC | 21,233,241 | 0 | 24,641,361 | 0 | SCHEDULE 13G/A, 2025-11-05 |
| Abigail P. Johnson | 0 | 0 | 24,641,361 | 0 | SCHEDULE 13G/A, 2025-11-05 |
The latest filing identifies Teva Pharmaceutical Industries Ltd. by CUSIP M8769Q102 and gives its principal executive office as 124 Dvora Hanevi'a Street, Tel Aviv (SCHEDULE 13G/A, 2026-11-02).
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-17 | Menora Mivtachim Holdings Ltd | 5% | SCHEDULE 13G |
| 2025-07-22 | Phoenix Financial Ltd. | 5% | SCHEDULE 13G |
| 2025-08-06 | Fmr LLC | 5.1% | SCHEDULE 13G/A |
| 2025-10-06 | Harel Insurance Investments & Financial Services Ltd | 5.1% | SCHEDULE 13G |
| 2025-11-05 | Fmr LLC | 2.1% | SCHEDULE 13G/A |
| 2026-02-09 | Harel Insurance Investments & Financial Services Ltd | 6.3% | SCHEDULE 13G/A |
| 2026-02-17 | Migdal Insurance & Financial Holdings Ltd | 5.37% | SCHEDULE 13G |
| 2026-11-02 | Harel Insurance Investments & Financial Services Ltd. | 6% | SCHEDULE 13G/A |
Questions about who owns Teva Pharmaceutical Industries Ltd.
Who owns Teva Pharmaceutical Industries Ltd.?
On this page, 4 holders' latest ownership filings report 5% or more of Teva Pharmaceutical Industries Ltd.: Harel Insurance Investments & Financial Services Ltd. (6%, Schedule 13G/A, filed 2026-11-02), Migdal Insurance & Financial Holdings Ltd (5.37%, Schedule 13G, filed 2026-02-17), Menora Mivtachim Holdings Ltd (5%, Schedule 13G, filed 2025-07-17) and Phoenix Financial Ltd. (5%, Schedule 13G, filed 2025-07-22).
Who are the largest shareholders of Teva Pharmaceutical Industries Ltd.?
By the share each holder's latest filing reports, the largest holders of Teva Pharmaceutical Industries Ltd. on this page are Harel Insurance Investments & Financial Services Ltd. (6%), Migdal Insurance & Financial Holdings Ltd (5.37%) and Menora Mivtachim Holdings Ltd (5%).
When did Harel Insurance Investments & Financial Services Ltd. buy into Teva Pharmaceutical Industries Ltd.?
The filings give report dates, not purchase dates. The earliest filing from Harel Insurance Investments & Financial Services Ltd. on this page is the Schedule 13G/A, filed 2026-11-02, reporting 6%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 8 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Teva Pharmaceutical Industries Ltd.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 29, 2026 | Leadership change: David J. Brailer appointed, Director | — | Leadership changes | Source |
Tools for this story
Each opens in a new tab, filled in for Teva Pharmaceutical Industries Ltd.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.